← SynDRA
KIN001-266
SynDRA canonical compound SYN0062532 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | MAP3K8 | TNF |
|---|
| Mechanism of action | MAPK-interacting kinase inhibitor |
|---|
Cross-references
Synonyms
- KIN-001-266
- RefChem:1074679
- DTXCID10608394
- cot-inhibitor-2
- Wyeth Cot Inhibitor 2
- C26H25Cl2FN8
- orb1710001
- SCHEMBL4962096
- SCHEMBL29971201
- BDBM29923
- CHEBI:91415
- PHNZIIMWDVXPGG-UHFFFAOYSA-N
- GLXC-26687
- HMS3295K05
- EX-A6263
- MFCD13184702
- AKOS027326464
- NCGC00273985-02
- NCGC00273985-03
- NCGC00273985-04
- NCGC00273985-05
- HY-32018
- MS-29942
- DB-015004
- F82196
- T10866
- substituted 6-aminoquinoline-3-carbonitrile, 34
- BRD-K49468759-001-01-8
- BRD-K49468759-001-04-2
- BRD-K49468759-001-05-9
- 8-Chloro-4-[(3-chloro-4-fluorophenyl)amino]-6-[[[1-(1-ethylpiperidin-4-yl)-1H-1,2,3-triazol-4-yl]methyl]amino]quinoline-3-carbonitrile
- 8-chloro-4-(3-chloro-4-fluoroanilino)-6-[[1-(1-ethyl-4-piperidinyl)-4-triazolyl]methylamino]-3-quinolinecarbonitrile
Look up KIN001-266 in the interactive SynDRA portal →